These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7588759

  • 21. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
    Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, Ward CW, Wallace JC.
    Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.
    Oh Y, Beukers MW, Pham HM, Smanik PA, Smith MC, Rosenfeld RG.
    Biochem J; 1991 Aug 15; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685
    [Abstract] [Full Text] [Related]

  • 26. A mutant of human insulin-like growth factor II (IGF II) with the processing sites of proinsulin. Expression and binding studies of processed IGF II.
    Zarn JA, Lüthi C, Giger RJ, Sigrist A, Humbel RE.
    Eur J Biochem; 1992 Dec 15; 210(3):665-9. PubMed ID: 1282887
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
    Clemmons DR, Dehoff ML, Busby WH, Bayne ML, Cascieri MA.
    Endocrinology; 1992 Aug 15; 131(2):890-5. PubMed ID: 1379166
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses.
    Macháčková K, Mlčochová K, Potalitsyn P, Hanková K, Socha O, Buděšínský M, Muždalo A, Lepšík M, Černeková M, Radosavljević J, Fábry M, Mitrová K, Chrudinová M, Lin J, Yurenko Y, Hobza P, Selicharová I, Žáková L, Jiráček J.
    J Biol Chem; 2019 Nov 15; 294(46):17371-17382. PubMed ID: 31558604
    [Abstract] [Full Text] [Related]

  • 31. Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II.
    Alvino CL, Ong SC, McNeil KA, Delaine C, Booker GW, Wallace JC, Forbes BE.
    PLoS One; 2011 Nov 15; 6(11):e27488. PubMed ID: 22140443
    [Abstract] [Full Text] [Related]

  • 32. Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling?
    Blakesley VA, Scrimgeour A, Esposito D, Le Roith D.
    Cytokine Growth Factor Rev; 1996 Aug 15; 7(2):153-9. PubMed ID: 8899293
    [Abstract] [Full Text] [Related]

  • 33. Engineering the C-region of human insulin-like growth factor-1: implications for receptor binding.
    Gill R, Wallach B, Verma C, Ursø B, De Wolf E, Grötzinger J, Murray-Rust J, Pitts J, Wollmer A, De Meyts P, Wood S.
    Protein Eng; 1996 Nov 15; 9(11):1011-9. PubMed ID: 8961354
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant.
    Slaaby R, Schäffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, Mathiasen IS, Brandt J.
    J Biol Chem; 2006 Sep 08; 281(36):25869-74. PubMed ID: 16831875
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
    Arai T, Clarke J, Parker A, Busby W, Nam T, Clemmons DR.
    J Biol Chem; 1996 Mar 15; 271(11):6099-106. PubMed ID: 8626396
    [Abstract] [Full Text] [Related]

  • 40. Evolution of insulin-like growth factor (IGF) function: production and characterization of recombinant hagfish IGF.
    Upton Z, Francis GL, Chan SJ, Steiner DF, Wallace JC, Ballard FJ.
    Gen Comp Endocrinol; 1997 Jan 15; 105(1):79-90. PubMed ID: 9000470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.